Essential Updates and Expert Perspectives in Gynecologic Malignancies: Independent 2024 Conference/Congress Coverage *

Review expert perspectives on the clinical implications of key studies covering gynecologic malignancies as presented at several 2024 oncology conferences and congresses via a downloadable living slideset, ClinicalThought commentaries, and podcasts.

Share

Program Content

Activities

2024 GYN CF
Essential Updates and Expert Perspectives in Gynecologic Malignancies: Independent 2024 Conference/Congress Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 30, 2024

Expires: July 29, 2025

Activities

GYN Conferences 2024 Midyear Highlights
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2024

Expires: January 24, 2025

Activities

Midyear Highlights: GYN Cancers
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2024

Expires: August 04, 2025

Faculty

cover img faculity

Floor J Backes, MD

Professor
Director of Clinical Research
Division of Gynecologic Oncology
Associate Fellowship Director
Department of Obstetrics and Gynecology
The Ohio State University College of Medicine
The James Cancer Hospital and Solove Research Institute
Columbus, Ohio

cover img faculity

Angeles Alvarez Secord, MD, MHSc

Professor of Obstetrics & Gynecology
Division of Gynecologic Oncology
Director, Gynecologic Oncology Clinical Trials
Associate Director, Clinical Research, Gynecologic Oncology Program
Duke Cancer Institute
Duke University Medical Center
Durham, North Carolina

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme LLC, and Seagen Inc.

AstraZeneca

Merck Sharp & Dohme, LLC

Seagen Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.